- |||||||||| Trial completion date, Trial primary completion date: BISER: Bacteriology and Inflammation in Bronchiectasis (clinicaltrials.gov) - Aug 28, 2018
P=N/A, N=80, Recruiting, Trial completion date: Dec 2017 --> Dec 2020 | Trial primary completion date: Dec 2017 --> Dec 2020
- |||||||||| levofloxacin / Generic mfg., trimethoprim/sulfamethoxazole / Generic mfg., azithromycin / Generic mfg.
Trial completion date, Trial primary completion date: Fluoroquinolone Associated Disability (clinicaltrials.gov) - Aug 13, 2018 P=N/A, N=100, Recruiting, N=4000 --> 6800 | Trial completion date: Feb 2019 --> Jun 2022 | Trial primary completion date: Feb 2019 --> Dec 2021 | Initiation date: Dec 2015 --> Apr 2016 Trial completion date: Jul 2018 --> Dec 2018 | Trial primary completion date: Jul 2018 --> Dec 2018
- |||||||||| AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial completion date, Trial primary completion date: Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) - Jul 24, 2018 P=N/A, N=20, Active, not recruiting, Recruiting --> Completed Trial completion date: Jun 2018 --> Jun 2019 | Trial primary completion date: Jun 2018 --> Jun 2019
- |||||||||| levofloxacin / Generic mfg., norfloxacin / Generic mfg., azithromycin / Generic mfg.
Trial completion, Enrollment change, Adverse events, Serious adverse event: A Study of Fluoroquinolones Exposure and Collagen-Related Serious Adverse Events (clinicaltrials.gov) - Jul 6, 2018 P=N/A, N=117911, Completed, Trial completion date: Jun 2018 --> Jun 2019 | Trial primary completion date: Jun 2018 --> Jun 2019 Active, not recruiting --> Completed | N=15000 --> 117911
- |||||||||| levofloxacin / Generic mfg., trimethoprim/sulfamethoxazole / Generic mfg., azithromycin / Generic mfg.
Enrollment open: Fluoroquinolone Associated Disability (clinicaltrials.gov) - May 31, 2018 P=N/A, N=100, Recruiting, Active, not recruiting --> Completed | N=15000 --> 117911 Not yet recruiting --> Recruiting
- |||||||||| levofloxacin / Generic mfg., trimethoprim/sulfamethoxazole / Generic mfg., azithromycin / Generic mfg.
New trial: Fluoroquinolone Associated Disability (clinicaltrials.gov) - May 27, 2018 P=N/A, N=100, Not yet recruiting,
- |||||||||| prednisolone / Generic mfg., levofloxacin / Generic mfg.
Trial completion date, Trial primary completion date: Effects of Oral Steroid in Mycoplasma Pneumoniae Pneumonia (clinicaltrials.gov) - Apr 27, 2018 P4, N=80, Recruiting, Trial primary completion date: Mar 2018 --> Jun 2019 Trial completion date: Dec 2018 --> Dec 2020 | Trial primary completion date: Dec 2017 --> Dec 2020
- |||||||||| Xerava (eravacycline) / SOM Biotech, Ewha Womans University, PAION, Innoviva
Trial completion, Trial completion date, Trial primary completion date: IGNITE3: Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections (clinicaltrials.gov) - Apr 11, 2018 P3, N=1200, Completed, Recruiting --> Active, not recruiting Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Jan 2018 | Trial primary completion date: Dec 2018 --> Dec 2017
- |||||||||| Trial completion date, Trial primary completion date: APPACIII: Antibiotics vs. Placebo in Acute Uncomplicated Appendicitis (clinicaltrials.gov) - Apr 9, 2018
P=N/A, N=147, Enrolling by invitation, Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Jan 2018 | Trial primary completion date: Dec 2018 --> Dec 2017 Trial completion date: Aug 2028 --> Aug 2029 | Trial primary completion date: Aug 2018 --> Mar 2019
- |||||||||| vancomycin / Generic mfg., levofloxacin / Generic mfg.
Trial completion, Phase classification, Enrollment change, Trial completion date: ANTHEM: Empirical ANtibiotic THErapy in Adults Hospitalised With Malaria (clinicaltrials.gov) - Mar 30, 2018 P, N=20, Completed, Not yet recruiting --> Recruiting Recruiting --> Completed | Phase classification: PN/A --> P | N=150 --> 20 | Trial completion date: Apr 2018 --> Jan 2018
- |||||||||| Orapenem (tebipenem pivoxil) / Meiji Seika, GSK
Enrollment change, Trial completion date, Trial primary completion date: Phase 1 Study of Safety, Tolerability and Pharmacokinetics of SPR994 (clinicaltrials.gov) - Mar 20, 2018 P1, N=152, Recruiting, N=500 --> 322 | Trial completion date: Dec 2018 --> May 2018 N=56 --> 152 | Trial completion date: Jan 2018 --> Aug 2018 | Trial primary completion date: Jan 2018 --> Aug 2018
- |||||||||| Noxafil (posaconazole) / Merck (MSD)
Trial completion date, Trial primary completion date: Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients (clinicaltrials.gov) - Mar 3, 2018 P=N/A, N=1000, Recruiting, N=56 --> 152 | Trial completion date: Jan 2018 --> Aug 2018 | Trial primary completion date: Jan 2018 --> Aug 2018 Trial completion date: Jan 2018 --> Mar 2018 | Trial primary completion date: Jan 2018 --> Mar 2018
- |||||||||| levofloxacin / Generic mfg.
Enrollment closed, Trial completion date, Trial primary completion date, Combination therapy: Efficacy and Safety of Levofloxacin for the Treatment of MDR-TB (clinicaltrials.gov) - Feb 27, 2018 P2, N=111, Active, not recruiting, Trial completion date: Jan 2018 --> Mar 2018 | Trial primary completion date: Jan 2018 --> Mar 2018 Completed --> Active, not recruiting | Trial primary completion date: Jul 2017 --> Mar 2019 | Trial completion date: Jul 2017 --> Mar 2019
- |||||||||| AzaSite (1% azithromycin ophthalmic solution) / Sun Pharma, Akorn, Nicox
Trial primary completion date: Healthy Patients & Effect of Antibiotics (clinicaltrials.gov) - Jan 29, 2018 P=N/A, N=20, Active, not recruiting, Not yet recruiting --> Recruiting | Initiation date: Feb 2018 --> Feb 2018 Trial primary completion date: Dec 2017 --> Jun 2018
- |||||||||| levofloxacin / Generic mfg.
Trial completion, Trial primary completion date: PK of Levofloxacin in MDR-TB Patients (clinicaltrials.gov) - Jan 25, 2018 P=N/A, N=20, Completed, Not yet recruiting --> Recruiting | Initiation date: Dec 2016 --> Aug 2017 Recruiting --> Completed | Trial primary completion date: May 2017 --> Oct 2017
- |||||||||| nitazoxanide / Generic mfg.
Trial primary completion date: A Two Week Nitazoxanidebased Quadruple Regimen (clinicaltrials.gov) - Jan 3, 2018 P3, N=100, Recruiting, Active, not recruiting --> Completed Trial primary completion date: Dec 2017 --> Dec 2022
|